USA drohen Europa mit Steuerkrieg wenn US-Konzerne mehr Steuern zahlen müssen - http://ift.tt/2bJ5hti

Berichte: USA verlagern Atomwaffen von der Türkei nach Rumänien - Error

Takeda agreed to fork over $8 million initially to Resolve as the startup works toward the start of first human studies in 2013 for the lead compound, RSLV-132, a nuclease Fc fusion protein. The deal includes backup compounds as well. And if planned Phase 1b/2a work for the front runner goes as hoped, Takeda could use its exclusive option from the deal and take over global development and commercialization of the compound, leading to up to $247 million in development payments to Resolve.

Takeda agreed to fork over $8 million initially to Resolve as the startup works toward the start of first human studies in 2013 for the lead compound, RSLV-132, a nuclease Fc fusion protein. The deal includes backup compounds as well. And if planned Phase 1b/2a work for the front runner goes as hoped, Takeda could use its exclusive option from the deal and take over global development and commercialization of the compound, leading to up to $247 million in development payments to Resolve.

Mission: WEST is a learning community that provides women in the enterprise of science and technology with the inspiration, knowledge, and connections to reach their full potential.  WEST is a community and forum, for early, mid-career, executive, and entrepreneurial women in STEM careers. WEST members are committed to developing themselves as leaders through education, mentorship, networking, and information sharing.

Mission: WEST is a learning community that provides women in the enterprise of science and technology with the inspiration, knowledge, and connections to reach their full potential. WEST is a community and forum, for early, mid-career, executive, and entrepreneurial women in STEM careers. WEST members are committed to developing themselves as leaders through education, mentorship, networking, and information sharing.

6th International Research Congress on Biocatalysis

Drug Delivery Technologies and Formulation Conference taking place on September 2012 in Zurich, Switzerland

EHR Vendors Targeting Small, Rural Hospitals Gaining in Popularity    Read more: http://www.ihealthbeat.org/articles/2012/10/24/ehr-vendors-targeting-small-rural-hospitals-gaining-in-popularity.aspx#ixzz2AswxHotf

EHR Vendors Targeting Small, Rural Hospitals Gaining in Popularity Read more: http://www.ihealthbeat.org/articles/2012/10/24/ehr-vendors-targeting-small-rural-hospitals-gaining-in-popularity.aspx#ixzz2AswxHotf

Banner for Pipeline pages

Banner for Pipeline pages

Why should farmers and ranchers advocate for agriculture? (Video) | Agriculture Proud

Why should farmers and ranchers advocate for agriculture? (Video) | Agriculture Proud

Der US-#Biotech-Konzern #Biogen soll im Visier von mehreren Übernahme-Interessenten stehen. Es soll bereits informelle Vorgespräche gegeben haben. Die möglichen Interessenten schweigen, Anleger reagieren sofort. Mehrere #Pharmaunternehmen sind einem Zeitungsbericht zufolge an einer Übernahme des US-Biotech-Konzerns Biogen interessiert.

Möglicher Mega-Deal: Mehrere Pharma-Unternehmen an Biogen interessiert

Biotech, Pharmaceutical, Medical Device, and Chemical Company Jobs in the State of California #pharmaceutical #industry #market #share pharma.nef2.com/... #pharmaceutical companies in orange county # VIVUS is developing and commercializing advanced therapeutic systems for the treatment of erectile dysfunction, commonly referred to as impotence. The company’s core technology, the transurethral system for erection, is based on the discovery that the urethra, although an excretory duct, c...

Biotech, Pharmaceutical, Medical Device, and Chemical Company Jobs in the State of California #pharmaceutical #industry #market #share pharma.nef2.com/... #pharmaceutical companies in orange county # VIVUS is developing and commercializing advanced therapeutic systems for the treatment of erectile dysfunction, commonly referred to as impotence. The company’s core technology, the transurethral system for erection, is based on the discovery that the urethra, although an excretory duct, c...

Apple: la empresa de más valor de todos los tiempos #infografia #infographic #apple

Apple: la empresa de más valor de todos los tiempos #infografia #infographic #apple

Johnson & Johnson’s acquisition of biotech company Actelion as well as more moderate competition from rival companies will reaccelerate top-line growth, according to one Wall Street firm. Wells Fargo raised its rating on J&J Monday, saying that improved performance could lead to... - #Fargo, #Finance, #JJ, #Shares, #Upgraded, #Wells

Johnson & Johnson’s acquisition of biotech company Actelion as well as more moderate competition from rival companies will reaccelerate top-line growth, according to one Wall Street firm. Wells Fargo raised its rating on J&J Monday, saying that improved performance could lead to... - #Fargo, #Finance, #JJ, #Shares, #Upgraded, #Wells

A Walk With Purpose: Memoir of a Bioentrepreneur #book #cancer #health    https://www.amazon.com/dp/B071HB2BY9/   With a prolific career in biotechnology serving as CEO of two companies who worked in the treatment and diagnosis of cancer Michael Becker knew and understood cancer. It was his job. So when he was looking in the mirror at age 47 and saw a lump in his neck that wasnt there the day before he knew something was wrong. After several tests and agonizing waiting periods for results…

A Walk With Purpose: Memoir of a Bioentrepreneur #book #cancer #health https://www.amazon.com/dp/B071HB2BY9/ With a prolific career in biotechnology serving as CEO of two companies who worked in the treatment and diagnosis of cancer Michael Becker knew and understood cancer. It was his job. So when he was looking in the mirror at age 47 and saw a lump in his neck that wasnt there the day before he knew something was wrong. After several tests and agonizing waiting periods for results…

Cher (seen above in April) is suing a biotech billionaire for allegedly tricking her into selling shares of a drug company just before its stock value skyrocketed

Cher claims she was duped to sell stocks in suit against pharm company

Cher (seen above in April) is suing a biotech billionaire for allegedly tricking her into selling shares of a drug company just before its stock value skyrocketed

Pinterest
Suchen